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H I G H L I G H T S
• Baseline depressive symptoms are associated with lower odds of smoking cessation.• This association is confounded by baseline heaviness of smoking and familial factors.• Factors underlying the association of smoking with depression warrant more research.
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A B S T R A C T
Depression has been suggested to hinder smoking cessation, especially when co-occurring with nicotine de-
pendence. The study aimed to examine the longitudinal association of depressive symptoms with smoking
cessation among daily smokers. The study utilized adult Finnish twin cohort where 1438 daily smokers (mean
age: 38.3, range: 33–45) in 1990 were re-examined for their smoking status in 2011. We assessed baseline
depressive symptoms with the Beck Depression Inventory, and the self-reported smoking status at follow-up. The
methods included multinomial logistic regression and time to event analyses, adjusted for multiple covariates
(age, sex, marital status, social class, heavy drinking occasions, and health status) and smoking heaviness at
baseline assessed by cigarettes per day (CPD). Additionally, within-twin-pair analyses were conducted. Results
indicated that moderate/severe depressive symptoms at baseline were associated with a lower likelihood of
smoking cessation two decades later. Adjusting for covariates, those with moderate/severe depressive symptoms
(vs. no/minimal depressive symptoms) had 46% lower likelihood of quitting (relative risk ratio, RRR = 0.54,
95% CI: 0.30–0.96). After including CPD, the association of depressive symptoms with smoking cessation at-
tenuated modestly (RRR = 0.62, 95% CI: 0.34–1.12). Further, time to event analysis for quitting year since
baseline yielded similar findings. In the within-pair analysis, depressive symptoms were not associated with
quitting smoking. The results suggest that reporting more depressive symptoms is associated with a lower
likelihood of smoking cessation during a 20-year period. The baseline amount of smoking and familial factors
partly explain the observed association. Smoking cessation programs should monitor depressive symptoms.
1. Introduction
Tobacco use is a major cause of mortality and morbidity, especially
among individuals with a psychiatric disorder (Royal College of
Psychiatrists, 2013). Quitting smoking reduces smoking-related mor-
tality (Thun et al., 2013). However, quitting may be especially chal-
lenging for depressed smokers (Ruther et al., 2014). Smokers with
psychiatric comorbidity may be as motivated to quit (Siru, Hulse, &
Tait, 2009), but more likely to relapse compared to general population
(Weinberger et al., 2017). To better understand the relationship be-
tween depressive symptoms and smoking cessation, it is crucial to in-
vestigate the association and its underlying mechanisms with long-term
prospective data.
Several factors influence smoking behavior and cessation. Smokers
easily become nicotine dependent as nicotine facilitates the release of
various neurotransmitters, for example, serotonin and dopamine
(Bruijnzeel, 2012; Picciotto, Brunzell, & Caldarone, 2002), while
chronic and high intake of nicotine results in adaptation in nicotinic
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pathways of the brain (Balfour & Ridley, 2000). Smokers with a co-
morbid depressive disorder may continue smoking to relieve their
symptoms, as suggested by the self-medication hypothesis (Khantzian,
2003). This is because nicotine may provide short-term compensation
for existing deficits in the cholinergic system, for example, related to
cognition, attention, arousal, motivational behaviors, and food satiety
(Laje, Berman, & Glassman, 2001). However, challenging this scenario,
smoking has been associated with an increase of depressive symptoms
(Vermeulen et al., 2019; Wootton et al., 2019), and smoking cessation
with improved mental health, wellbeing, and quality of life (Taylor
et al., 2014).
Furthermore, low positive or high negative affect, cognitive im-
pairment, inability to feel pleasure, anxiety sensitivity, and distress
tolerance have been found to be associated with relapse and un-
successful quitting (Ameringer & Leventhal, 2010; Leventhal &
Zvolensky, 2015; Mathew, Hogarth, Leventhal, Cook, & Hitsman,
2017). Thus, compared to non-depressed smokers, depressed smokers
exhibit a higher negative affective state, which may promote continued
smoking behavior.
Additionally, the association between depression and smoking ces-
sation could be attributable to shared familial factors (Rose, Broms,
Korhonen, Dick, & Kaprio, 2009). Smoking behavior is genetically
correlated with major depressive disorder (Liu et al., 2019). However,
despite the underlying mechanisms, successful quitting predicts a de-
crease in depressive symptoms (Taylor et al., 2014), whereas, un-
successful quitters are more likely to experience depression later
(McClave et al., 2009). Moreover, patients with depression can suc-
cessfully quit smoking if provided with effective interventions
(Gierisch, Bastian, Calhoun, McDuffie, & Williams, 2012; Secades-Villa,
Gonzalez-Roz, Garcia-Perez, & Becona, 2017).
Longitudinal population-based studies are important as they pro-
vide information on the nature of the association in an unselected po-
pulation of smokers. In this study, we seek to describe and better un-
derstand the association between depressive symptoms and smoking
cessation outcome after 20 years of follow-up in adulthood. The main
aim of the present study was to investigate whether depressive symp-
toms predict poor smoking cessation outcome. If so, our further re-
search question was whether the observed association is independent of
confounding factors.
2. Method
2.1. Sample
The Adult Finnish Twin Cohort is a population-based sample com-
piled from the Central Population Registry consisting of all same sex
twin pairs born in Finland before 1958 with surveys starting in 1975.
Next surveys of the cohort were in 1981, 1990, and 2011, respectively
(Kaprio & Koskenvuo, 2002; Kaprio et al., 2019). This specific study
utilized data from the third and fourth waves of the surveys. In 1990, a
questionnaire was sent to twins born in 1930–1957, who had responded
to one of the previous surveys. The response rate was 77%, with 12,502
respondents. In 2011, a questionnaire was sent to twins born
1945–1957 irrespective of participation in any earlier survey. Out of
11,766 persons alive and residing in Finland, 8410 responded, yielding
a response rate of 72%. In the 1990 survey, 3053 participants reported
being a current daily smoker and responded to items on depressive
symptoms. Of daily smokers in the 1990 survey, 1473 participated in
the 2011 questionnaire survey (1189 born in 1930–1944 or died were
excluded and 391 did not participate the follow-up). After including
only those who had provided complete information on smoking status
at the 2011 follow-up and depressive symptoms in 1990, we studied
1438 participants. The mean age at the baseline was 38.3 years. There
were 693 males and 745 females. Of the participants, 459 (31.9%) were
monozygotic (MZ) twins, 881 (61.3%) were dizygotic (DZ) twins, and
98 (6.8%) were of unknown zygosity. Ethical permissions for the Adult
Twin Cohort surveys were obtained from the Ethics committee of the
Department of Public Health, University of Helsinki and University
District Hospital of Helsinki and Uusimaa, Finland.
2.2. Measures
2.2.1. Depressive symptoms
The 1990 baseline survey assessed depressive symptoms using the
Beck Depression Inventory (BDI), the 21-item questionnaire where in-
structions guide the participants in describing their symptoms and at-
titudes as they perceive them ‘right now’ in terms of intensity from 0 to
3 (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). The BDI has high
internal consistency, with alpha coefficient of 0.86 for depressed and
0.81 for non-depressed population (Beck, Steer, & Carbin, 1988). The
BDI sum score ranges from 0 to 63. We created three depression cate-
gories based on the sum scores: 1) 0–9 (none or minimal depression); 2)
10–16 (mild depression); and 3) 17 or higher (moderate/severe de-
pression) which is nearly identical to the guidelines for BDI cut‐points
of scores (Beck et al., 1988). More details of BDI have been provided in
a previous study based on the 1990 survey (Varjonen, Romanov,
Kaprio, Heikkilä, & Koskenvuo, 1997). For the analysis, the BDI sum
score was also utilized as a continuous variable (min–max score: 0–37).
In sensitivity analyses, we used the Center for Epidemiologic Studies
Depression (CES-D) scale to assess depressive symptoms at the follow-
up (Radloff, 1977). The CES-D scale includes 20 items assessing fre-
quency of depressive symptoms and ranging from 0 to 3. The sum score
ranged from 0 to 60, and a cut off value ≥ 20 was used to identify a
participant with depression (Vilagut, Forero, Barbaglia, & Alonso,
2016).
2.2.2. Smoking status and quitting smoking
To classify smoking status participants were asked, “Have you
smoked more than 5–10 packs of cigarettes in your lifetime?”, being
comparable with the commonly used threshold of 100 cigarettes life-
time exposure. Those responding negatively were considered as ‘never
smokers’ and those responding positively were further asked, “Do you
smoke, or have you smoked cigarettes regularly, say daily or almost
daily during your lifetime?” Those who replied negatively were con-
sidered as ‘occasional smokers’; (i.e. non-daily smokers). Those who re-
plied positively were further queried, “Do you still smoke cigarettes
regularly?” If so, they were classified as ‘current daily smokers’ and if
not, they were classified as ‘former smokers’ (regular smokers who had
responded that they no longer smoked at the time of the survey) (Kaprio
& Koskenvuo, 1988). The present study includes only those who were
classified as ‘current daily smokers’ at the baseline in 1990. In their
subsequent follow-up (2011), smoking status was classified in three
categories: 1) Current daily smokers; 2) Occasional smokers; and 3)
Former smokers, i.e. successful quitters.
‘A time of quitting’ since baseline variable was created for time-to-
event analysis (see below). In the 2011 questionnaire, respondents were
asked, “How old were you when you stopped smoking?”. Based on their
response and the age at the time of surveys, we created the ‘year of
quitting’ variable. Those who had quit during 1990–2011 were con-
sidered as former smokers, and all others (current and occasional
smokers in 2011) were censored after the end of follow-up (2011).
2.2.3. Amount of smoking and use of nicotine replacement therapy
Cigarettes smoked per day (CPD) is one of the two items in the
Heaviness of Smoking Index (Heatherton, Kozlowski, Frecker, Rickert,
& Robinson, 1989), a short measure of nicotine dependence. To de-
termine CPD at study baseline, participants were asked, “How many
cigarettes do you smoke daily on average?” and categorized as “1–9
cigarettes”, “10–19 cigarettes”, and “20 or more cigarettes”.
In sensitivity analyses, we adjusted for use of nicotine replacement
therapy (NRT) as a cessation aid. In the 2011 follow-up questionnaire
participants were asked “Have you during the past year (12 months)
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used nicotine replacement therapy (gum, patch, lozenge etc.)?”, the
responses classified as “No, I have not used NRT/I have used NRT for
other reason than smoking cessation” and “Yes, I have used NRT as a
smoking cessation aid”. Those who did not use NRT or used NRT for
other reason were combined to create a reference category.
2.2.4. Covariates
We included several covariates assessed at baseline, capturing a) so-
ciodemographic factors (age, sex, marital status, and social class); b)
health status; and c) heavy drinking occasions (alcohol use). These cov-
ariates were considered based on a careful literature review and identified
as potential confounders for the association between depression and
smoking cessation (Chaiton, Cohen, Rehm, Abdulle, & O'Loughlin, 2015;
Huffman, Bromberg, & Augustson, 2018; Weinberger et al., 2017).
For marital status, participants were asked, “What is your marital
status?”, and the responses were categorized as “married” (including
remarried or cohabiting) or “single” (comprising single, divorced and
widowed). Social class was defined by years of education and type of
work (Appelberg, Romanov, Honkasalo, & Koskenvuo, 1991). Those
who had a minimum of 12 years of education and performing sedentary
work were categorized “high” (‘white collar’); those who had< 9 years
of education and performed physical work were “low” (‘blue collar’)
and these remaining represented an intermediate group “medium”. To
determine health status, a Somatic Disease Index was created based on
self-reports. A participant was considered to have a somatic disease if
he/she reported one of the following: i) a disease diagnosed by a
physician (a list of 20 chronic conditions such as asthma, hypertension,
diabetes, and cancer), ii) serious injury/illness or iii) work disability.
Others were considered as ‘healthy’ (Romanov, Varjonen, Kaprio, &
Koskenvuo, 2003). To determine heavy drinking occasions (Sipila,
Rose, & Kaprio, 2016), participants were asked “Does it happen that at
least once a month and on the same occasion you drink more than five
bottles of beer or more than a bottle of wine or more than half a bottle
of hard liquor?” and the response was categorized as “no” or “yes”.
2.3. Statistical analyses
First, we conducted multinomial logistic regression analyses to
study the association between baseline depressive symptoms and
smoking status at follow-up. BDI was included as a three-category
variable (None/Minimal (0–9), Mild (10–16), and Moderate/Severe (17
or more)) based on the sum scores. We also used the BDI sum score as a
continuous variable. Daily smokers were used as the reference category
of smoking status at follow-up. In the analyses, twins were treated as
individuals, but because observations on twins within twin pairs are not
independent, cluster-robust standard errors were estimated (Williams,
2000). The analysis was first adjusted for age and sex to estimate the
crude association between depressive symptoms and smoking cessation.
We then adjusted for marital status, social class, heavy drinking occa-
sions, and health status to observe if the association attenuated after
adjusting for multiple confounders. The final model included ad-
ditionally CPD to test the influence of smoking heaviness on the asso-
ciation. Males and females were pooled together in the analyses be-
cause there was no evidence for a sex*depressive symptoms interaction
(Likelihood Ratio test, chi2(4) = 4.96, p = 0.29).
To strengthen our findings, we conducted time-to-event analysis to
observe if depressive symptoms at baseline predicted timing of quitting
smoking. We followed participants from 1990 until 2011 and recorded
the year of quitting, therefore, studying the time to event between
depressive symptoms and quitting smoking. All analyses were adjusted
for the same co-variates. We estimated Relative Risk Ratios (RRR) and
Hazard Ratios (HR) with 95% confidence intervals (CI) and considered
p < 0.05 as statistically significant.
Additionally, we conducted within-pair-analysis as a fixed effects
model (conditional logistic regression) (Allison, 2009). In the analysis,
to gain statistical power, occasional and daily smokers were pooled as
“current smokers” and mild and moderate/severe depressive symptoms
into one category. Similarly, MZ and DZ pairs were pooled together.
The fixed effects models use data from co-twins who differ regarding
depression and thus control for possible unmeasured confounding due
to genetic influences and other factors shared by the co-twins.
We conducted two sensitivity analyses. First, we additionally ad-
justed the analysis with depressive symptoms measured at follow-up.
Second, we performed a sensitivity analysis among the sub-sample of
remaining smokers vs. quitters during the past year before follow-up.
We adjusted the analysis for NRT use during 2010–2011 to observe if
the association between depressive symptoms and quitting smoking was
explained by pharmacological treatment. All statistical analyses were
conducted with Stata (version 15) (StataCorp. , 2015).
3. Results
3.1. Descriptive data
Of daily smokers at baseline, 38% had quit smoking, 6% had be-
come occasional smokers, and more than half remained daily smokers
at the follow-up (Table 1). Five percent of participants reported mod-
erate/severe depressive symptoms (mean score: 5.3). Most of those with
moderate/severe depressive symptoms, continued to be daily smokers
at the follow-up. There were more males than females among quitters.
Of those having moderate/severe depressive symptoms, 49% smoked
20 or more CPD whereas the proportion was significantly smaller
among those with mild or none/minimal depressive symptoms
(Chi2(4) = 18.55, p < 0.05; not shown in the Table).
3.2. Association between baseline depressive symptoms and smoking status
at follow-up
Having moderate/severe (vs. none/minimal) depressive symptoms
halved the likelihood of smoking cessation at follow-up (RRR = 0.50,
95% CI: 0.28–0.89) (Table 2). Adjusting for multiple covariates only
slightly attenuated the association (RRR = 0.54, 95% CI: 0.30–0.96).
To control for baseline differences in the amount of smoking, CPD was
added to the model. The RRR estimate was now more attenuated and
statistically non-significant (RRR = 0.62, 95% CI: 0.34–1.12). Further,
reporting more depressive symptoms was also associated with a lower
likelihood of becoming an occasional smoker, but the association was
statistically non-significant (age and sex adjusted RRR = 0.55, 95% CI:
0.17–1.82). When depressive symptoms were analyzed as a continuous
variable, the results were consistent with the main analysis (not shown
in the Table). Reporting more depressive symptoms predicted a lower
likelihood of quitting smoking when adjusted for all covariates except
CPD (RRR = 0.98, 95% CI: 0.96–1.00, p = 0.031). Additional adjust-
ment for CPD attenuated the significance but not the point estimate
(RRR = 0.98, 95% CI: 0.96–1.01, p = 0.15).
3.3. Association between depressive symptoms and time of quitting
The Cox proportional-hazards models for the time of quitting since
baseline provided similar results as the first analysis. Adjusted for age
and sex, the Hazard Ratio of smoking cessation among those having
moderate/severe (vs. none/minimal) depressive symptoms was 0.58
(95% CI: 0.36–0.96) (Table 3). The association attenuated after ad-
justing for other covariates. The Kaplan-Meier survival curves show that
those reporting higher depressive symptoms were less likely to quit
smoking over the follow-up period (Fig. 1).
3.4. Familial factors, depressive symptoms and smoking status: Within-pair
analysis
Accounting for shared familial factors in the within-pair analysis,
there was no association between depressive symptoms at baseline and
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smoking status at follow-up (OR = 1.14, 95% CI: 0.41–3.15, p = 0.80)
(Supplementary Table A.1).
3.5. Sensitivity analyses
When adjusting for depressive symptoms at follow-up, the point
estimates of the association between baseline depressive symptoms and
quitting smoking were very similar to the main results (Supplementary
Table A.2). Among the sub-sample of remaining smokers and those who
quit during 2010–2011, the association between baseline depressive
symptoms and smoking status was not explained by past-year NRT use
(Supplementary Table A.3).
Table 1
Descriptive characteristics of daily smokers in 1990 by smoking status in 2011.
Characteristics Total Current daily smokers Occasional smokers Former smokers
N = 1438 N = 799 (55.5%) N = 90 (6.3%) N = 549 (38.2%)
BDI (1990)
None/Minimal (%) 1179 (82.0) 639 (80.0) 75 (83.3) 465 (84.7)
Mild (%) 190 (13.2) 111 (13.9) 12 (13.3) 67 (12.2)
Moderate/Severe (%) 69 (4.8) 49 (6.1) 3 (3.3) 17 (3.1)
BDI score (1990)
Mean (SD) 5.3 (5.7) 5.8 (6.0) 4.7 (5.1) 4.8 (5.2)
Score min–max 0–37 0–37 0–29 0–34
Median (Q1, Q3) 4 (1,8) 4 (1,8) 3 (1,6) 3 (1,7)
None/Minimal Mean (SD) 3.2 (2.7) 3.4 (2.8) 2.8 (2.5) 3.1 (2.7)
Mild Mean (SD) 12.3 (2.0) 12.4 (2.0) 12.1 (1.9) 12.2 (2.0)
Moderate/Severe Mean (SD) 22.6 (4.8) 22.4 (4.9) 21.3 (6.6) 23.2 (4.6)
Age, Years
Mean (SD) 38.3 (3.6) 38.1 (3.6) 38.4 (3.5) 38.7 (3.7)
Sex
Male (%) 693 (48.2) 360 (45.1) 49 (54.4) 284 (51.7)
Female (%) 745 (51.8) 439 (54.9) 41 (45.6) 265 (48.3)
Social class
Low (%) 676 (47.0) 387 (48.4) 38 (42.2) 251 (45.7)
Medium (%) 644 (44.8) 358 (44.8) 38 (42.2) 248 (45.2)
High (%) 118 (8.2) 54 (6.8) 14 (15.6) 50 (9.1)
Chronic Illness/Disability
No (%) 682 (47.4) 372 (46.6) 45 (50.0) 265 (48.3)
Yes (%) 756 (52.6) 427 (53.4) 45 (50.0) 284 (51.7)
Marital status
Married (%) 1061 (73.8) 580 (72.6) 64 (71.1) 417 (76.0)
Single (%) 375 (26.1) 217 (27.2) 26 (28.9) 132 (24.0)
Missing (%) 2 (0.1) 2 (0.2) 0 0
Heavy drinking occasions
No (%) 732 (50.9) 398 (49.8) 41(45.6) 293 (53.4)
Yes (%) 697 (48.5) 398 (49.8) 48 (53.3) 251 (45.7)
Missing (%) 9 (0.6) 3 (0.4) 1 (1.1) 5 (0.9)
Cigarettes per day
Up to 9 cigarettes (%) 400 (27.8) 165 (20.7) 51 (56.7) 184 (33.5)
10–19 cigarettes (%) 611 (42.5) 367 (45.9) 19 (21.1) 225 (41.0)
20 or more (%) 421 (29.3) 267 (33.4) 18 (20.0) 136 (24.8)
Missing (%) 6 (0.4) 0 2 (2.2) 4 (0.7)
N = Total number.
SD = Standard Deviation.
Q1 = 1st quartile.
Q3 = 3rd quartile.
BDI = Beck Depression Inventory.
Table 2
Relative Risk Ratios (RRR) and 95% Confidence Intervals (CI) for smoking status at follow-up by depressive symptoms at baseline (N = 1438).
Depressive symptoms predicting smoking status Adjusted for age and sex Adjusted for covariatesa Adjusted for covariatesa and CPD
RRR 95% CI P RRR 95% CI P RRR 95% CI P
Occasional smoker vs Daily smoker (ref)
None/Minimal 1.00 1.00 1.00
Mild 0.97 0.51–1.85 0.92 0.95 0.49–1.83 0.87 1.11 0.57–2.17 0.76
Moderate/Severe 0.55 0.17–1.82 0.33 0.62 0.18–2.09 0.44 0.86 0.25–2.98 0.82
Former smoker vs Daily smoker (ref)
None/Minimal 1.00 1.00 1.00
Mild 0.86 0.62–1.20 0.39 0.90 0.64–1.25 0.50 0.93 0.67–1.31 0.69
Moderate/severe 0.50 0.28–0.89 0.018 0.54 0.30–0.96 0.037 0.62 0.34–1.12 0.11
CPD = Cigarettes per day.
N = Total number.
a Age, sex, social class, health status, marital status, and heavy drinking occasions.
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4. Discussion
In a prospective 20-year follow-up study of daily smokers, we found
higher level of depressive symptoms to predict lower likelihood of
smoking cessation. The association appears to be robust when adjusting
for multiple covariates, yet partly explained by smoking heaviness as
well as by familial factors. Overall, our findings support and expand the
earlier results that depressive symptoms predict less successful quitting
(Hitsman et al., 2013; Huffman et al., 2018; Kenney et al., 2009).
We found that moderate/severe depressive symptoms predicted a
lower likelihood of smoking cessation at follow-up. The time-to-event
analysis further supported these findings. This is in line with a meta-
analysis which found that depressed smokers had 17% lower odds of
short-term abstinence and 19% lower odds of long-term abstinence
compared to non-depressed (Hitsman et al., 2013). Furthermore, in-
dividuals with a history of two or more lifetime mental illnesses and
comorbid depression were 66% less likely to quit smoking than those
who had multiple mental illnesses but not depression (Huffman et al.,
2018). Thus, overall, findings suggest depressive symptoms as a chal-
lenge for smoking cessation.
To control for the baseline differences in amount of smoking, CPD
was added to the model, and the association attenuated modestly. This
suggests that amount of smoking may have a role in the association
between depression and smoking cessation. Apart from CPD, other
substance abuse, such as alcohol abuse and dependence, may confound
the relationship between depressive symptoms and smoking cessation
(Kenney et al., 2009). However, in our sample heavy drinking did not
influence the results. Further, although depressive symptoms seemed to
associate with a lower likelihood to become an occasional smoker, the
association was non-significant. In sensitivity analyses, the association
between depression and quitting was not explained by differences in
NRT use. However, a meta-analysis reported that NRT had a small,
positive effect among depressed smokers (Gierisch, Bastian, Calhoun,
McDuffie, and Williams, 2010).
Furthermore, the within-pair analysis found no association between
depressive symptoms and smoking cessation, suggesting that the in-
dividual-level associations were, at least partially, due to shared fa-
milial influences. Consistent with our finding, an earlier twin study
found a modest genetic correlation (r = 0.32) between depression and
nicotine dependence (Edwards & Kendler, 2012), implying that persons
having genetic vulnerability to depression also have a higher liability
for nicotine dependence. In a recent genome‐wide association meta‐a-
nalysis, there was a modest genetic correlation (r = 0.26) between
major depressive disorder and smoking cessation (Liu et al., 2019). In
another twin study, the relationship among depression, regular tobacco
use and nicotine dependence was explained partially by shared familial
factors (Edwards, Maes, Pedersen, & Kendler, 2011). In contrast, a fa-
mily study including first-degree relatives of the participants found no
increased risk of smoking among relatives of the person with depression
(Dierker, Avenevoli, Stolar, & Merikangas, 2002), not supporting a
shared liability between depression and heavy smoking. Thus, under-
standing the role of shared familial factors for the relationship between
depressive symptoms and smoking cessation remains a challenge for
future studies.
There are several hypotheses why depressed smokers continue
smoking and are less successful in quitting. The self-medication hy-
pothesis states that individuals with a psychiatric condition smoke to
relieve their symptoms (Khantzian, 2003). It is suggested that nicotine
can lessen the symptoms of depression in the short-term and nicotine
abstinence can accelerate withdrawal symptoms such as depressed
mood (Bruijnzeel, 2012; Picciotto et al., 2002). Additionally, psycho-
logical mechanisms such as low positive affect, high negative affect,
cognitive impairment, anhedonia, and anxiety sensitivity can hinder
smoking cessation among depressed individuals (Ameringer &
Leventhal, 2010; Leventhal & Zvolensky, 2015; Mathew et al., 2017).
Other reasons include concern regarding weight gain, interaction with
treatment for mental disorder (Royal College of Psychiatrists, 2013),
ineffective cessation intervention, and failure in relapse prevention
(Ruther et al., 2014). Moreover, it should be noted that low motivation
to quit may be a symptom of depression itself, and lower self-efficacy
may contribute to fewer quit attempts and/or seeking out treatments.
Effective smoking cessation interventions are needed for those suf-
fering from depression. Pharmacological treatment and non-pharmaco-
logical approaches, for example, tailored quit line program, and an or-
ganizational change approach in behavioral health care settings are
equally important (Secades-Villa et al., 2017; Steinberg, Weinberger, &
Tidey, 2019). It is inevitable that depressed smokers require more support
during smoking cessation, and combined interventions are necessary for
addressing the disparity (Aldi, Bertoli, Ferraro, Pezzuto, & Cosci, 2018).
Our findings have implications for future research. We found that
baseline amount of smoking and familial factors play a role in the as-
sociation between depressive symptoms and smoking cessation. Most
Table 3
Hazard Ratios (HR) and 95% Confidence Intervals (CI) for time to quitting (years) since baseline by depressive symptoms (N = 1280).
Depressive symptoms predicting quitting smoking Adjusted for age and sex Adjusted for covariatesa Adjusted for covariatesa and CPD
HR 95% CI P HR 95% CI P HR 95% CI P
None/Minimal 1.00 1.00 1.00
Mild 0.83 0.62–1.11 0.22 0.87 0.64–1.16 0.34 0.89 0.66–1.19 0.42
Moderate/Severe 0.58 0.36–0.96 0.035 0.62 0.37–1.02 0.059 0.68 0.41–1.13 0.14
CPD = Cigarettes per day.
N = Total number.
a Age, sex, social class, health status, marital status, and heavy drinking occasions.
Fig. 1. Kaplan-Meier curves for quitting as a function of time (in years) since
baseline by categories of depressive symptoms. The survival probability shows
the fraction of baseline smokers who have quit by time since 1990. The dotted
line (…..) is for smokers with none or minimal symptoms of depression, the
dashed line ( −−−−) for those with mild symptoms and the continuous line
for those with moderate to severe symptoms.
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smokers with psychiatric co-morbidities are interested in quitting but
more research and development are required within smoking cessation
treatments to understand which characteristics of the individual and
the treatment are predictive of successful cessation, and how best to
tailor the cessation programs for this vulnerable population group.
4.1. Strengths and limitations
Among the strengths of this study is that depressive symptoms were
measured using BDI, a widely used and well-known instrument to
capture self-rated depressive symptoms. Next, we were able to include a
large sample of daily smokers at the baseline and assess changes in their
smoking status for 20 years. This included not only quitters but also
those who became non-daily smokers. Further, we were able to control
for both measured covariates and unmeasured familial factors. The
study findings among twins are generalizable to the general population
because the information on twins was based on population-based
sample with relatively high response rates, and twins are not different
from singletons in terms of depression or smoking behavior (Kendler,
Martin, Heath, & Eaves, 1995; Ware et al., 2016).
The extended follow-up period of 20-years is also a potential lim-
itation as smoking status may have changed more than once, i.e. re-
spondents may have quit smoking and relapsed again. Secondly, age at
quitting was self-reported and retrospective in nature and can include
recall bias; but it would be unlikely to depend on depression assessed at
baseline. Third, we did not have information on baseline co-morbid
psychiatric diagnoses. Fourth, the BDI mean score for the total sample
was quite low: only 4.8% of participants scored 17 or more at the
baseline. BDI score had a floor effect which is common in population-
based samples. Underreporting is also a possibility in self-reported
measures. Fifth, we used the baseline amount of smoking (CPD) to in-
dicate smoking heaviness. It would have been optimal to also include
Time to First Cigarette of the day as the other item of the Heaviness of
Smoking Index, however, we only had information regarding CPD.
Finally, in the within-twin pair analysis, the number of pairs was in-
sufficient for conducting meaningful analyses separately by zygosity.
4.2. Conclusions
Our findings provide further support for a longitudinal association
between depressive symptoms and lower likelihood of smoking cessa-
tion. This association may partly be explained by the baseline amount
of smoking and shared familial factors. To deepen understanding on the
role of depression in smoking cessation, it is crucial to examine the
underlying mechanisms that may explain this association. Smoking
cessation interventions and treatments should monitor depressive
symptoms throughout both before and after the quitting.
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